Clinical trial
Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)
NCT00434096 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00434096 |
|---|---|
| Title | Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS) |
| Official title | A Randomized Double-blind, Placebo-controlled, Parallel-group, Fixed Single-dose Regimen (SR141716 20 mg), Multicenter Study to Assess the Efficacy and Safety of SR141716 in Obese Patients With Dyslipidemia. |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | rimonabant (SR141716), placebo |
| Enrollment | 915 |
| Start date | Feb 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Feb 1, 2009 |
| First posted | Feb 12, 2007 |
| Last update posted | Jul 20, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: